Recall of participation in research projects in cancer genetics: Some implications for research ethics

Clinical Ethics

Volumn 3, Issue 4, 2008, Pages 180-184

  Cooke, Sarah ^a   Crawford, Gillian ^b   Parker, Michael ^c   Lucassen, Anneke ^b   Hallowell, Nina ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992810091     PISSN: 14777509     EISSN: 1758101X     Source Type: Journal    
DOI: 10.1258/ce.2008.008019     Document Type: Article

References (13)

1. Declaration of Helsinki. Ethical Principles for Medical Research involving Human Subjects. 5th edn. Edinburgh: World Medical Association, 2000.
2. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulation and the administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities-Legislation 2000; 121: 34.
3. Brown RF, Butow PN, Butt DG, Moore AR, Tattersall MH. Developing ethical strategies to assist oncologists in seeking informed consent to cancer trials. Soc Sci Med 2004; 58: 379-90.
4. Featherstone K, Donovan JL. ‘Why don't they tell me straight, why allocate it?’ The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med 2002; 55: 709-19.
5. Joffe S, Cook E, Cleary PD, Clark JW, Weeks J. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001; 358: 1772-7.
6. Snowdon C, Garcia J, Elbourne D. Making sense of randomization: responses of parents of critically ill babies to random allocation of treatment in a clinical trial. Soc Sci Med 1997; 45: 1337-55.
7. Lidz CW, Appelbaum PS, Gisso T, Renaud M. Therapeutic misconception and the appreciation of risk in clinical trials. Soc Sci Med 2004; 58: 1689-97.
8. Parker M, Ashcroft R, Wilkie AOM, Kent A. Ethical review of research into rare genetic disorders. BMJ 2004; 329: 288-9.
9. Hallowell N, Cooke S, Crawford G, Parker M, Lucassen A. Translating research into practice: health care professionals' and researchers' understanding of cancer genetics activities in the UK. ESRC Genomics Network Conference Genomics and Society: Today's Answers, Tomorrow's Questions. London: 25-26 October 2007.
10. Lawton J, Gaining and maintaining consent: ethical concerns raised in a study of dying patients. Qual Health Res 2001; 11: 693-705.
11. Shuhatovich O, Sharman M, Mirabal Y, Earle N, Follen M, Basen-Engquist K. Participation recruitment and motivation for participation in optical technology for cervical cancer screening research trials. Gynecol Oncol 2005; 99: S226-32.
12. Ponder M, Statham H, Hallowell N, Moon J, Richards M, Raymond FL. Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research. J Med Ethics (in press).
13. Yentis SM, Dawson AJ. Medical studies with ‘no material ethical issues’ an unhelpful, confusing and potentially unethical suggestion. Clinical Ethics 2006; 1: 234-6.